Kevin Kunzmann

The label update comes after findings have repeatedly shown an associated risk of neuropsychiatric events.

New data evidences yet another IL-13 targeting biologic for atopic dermatitis.

Everyone has an opinion. But what do the actual experts think?

The RareWear program is designed to bridge medical device companies to rare disease patient applicants, seeking better disease and treatment monitoring.

New research suggests proposals aimed at reducing out of pocket costs may harm minimally-funded drug developers.

An emphasis on collecting and assessing quality-of-life biomarkers shows promise for tailoring treatment of the rare condition.

What is the primary care physician's role in detecting the rare hepatologic condition?

The Ready, Set, Food! co-founder discusses how research and federal advisory shapes parental understanding of immunotherapy and food allergy prevention.

As symptoms reportedly reach the majority of the US physician population, it's time to discuss individual strategy to reduce the risk and effect of burnout.

How can primary care and family physicians help put concerned patients at ease?

A look back on the biggest discussions of the 29th Annual Cardiovascular Conference in Beaver Creek, CO.

A pair of colleagues from Duke detail what makes the annual cardiovascular meeting beneficial to researchers and clinicians.

A new guidance breaks ground as the first of its kind to assist physicians in screening for, and treating, vaping-associated respiratory disease syndrome.

New follow-up data shows older patients with COPD characterized by high blood eosinophil counts may benefit from the biologic.

What do you see as the broken cogs of the US healthcare system? Join our Monday night chat to share your thoughts!

A pediatric gastroenterologist shares insight into building a strong trust with both patients and their families.

New VDAART follow-up findings show at-risk children are not safer from asthma or recurrent wheeze when their mother takes prenatal vitamin D.

What does a strong physician-patient connection look like in 2020?

The family medicine physician shares perspective on the differing healthcare teams, and what her practice could most benefit from.

A comparative assessment shows children with psoriasis have a four-fold increased risk of reaching PASI 75 with biologics.

The oral treatment becomes the first of its kind indicated for the reduction of food allergic reaction risks and severity in the US.

New research into the role of legislation on vaping use shows certain laws may be more effective than others.

A family physician takes lead on a discussion around the changing makeup of care teams.

New cohort data shows significantly worsened respiratory symptoms among patients with comorbid cough and COPD.

The FDA will rule on the type 2 inflammation-targeting biologic for another indication this May.

The SoMeDocs founder shares thoughts on doctors developing an online brand, the burden of being an uncredited expert on social media, and the benefit of committing to the platforms.

An oral tablet combining empagliflozin, linagliptin, metformin hydrochloride will soon be available on US markets.

A new meta-analysis shows deep association between trauma severity, capability of care, and a military veteran's adherence to masculine ideologies.

SoMeDoc's founder leads the inaugural chat between the #DocTalk and #SoMeDocs communities.

New findings show a greater risk of longer, more persistent cases of atopic dermatitis among children with mothers suffering from depression.